×

not available

upload cover

Comparación de indapamida SR 1,5 mg. con 5 mg. de amlodipino y 25 mg. de hidrocloratiazida en pacientes hipertensos de edad avanzada

Estudio aleatorio...

The book Comparación de indapamida SR 1,5 mg. con 5 mg. de amlodipino y 25 mg. de hidrocloratiazida en pacientes hipertensos de edad avanzada has been registred with the ISBN 978-987-515-266-3 in Agencia Argentina de ISBN Cámara Argentina del Libro. This book has been published by Waverly Hispánica in 2001 in the city Florida, in Argentina.

In addition to this record, there are another 698 books published by the same publisher. Standing out: Pediatric infectious disease journal written by Eli Lahat, Georges Peter and Henry F. Pabst Datos recientes sobre streptococcus preumoniae resistentes written by George H. Mc Cracken Quinaprilat induce vasodilatación arterial por óxido nítrico en humanos written by Linder L. Haejeli We and Lüscher Hospital infection control written by Juan José Picazo and Geriatrics review syllabus 1998 .

ISBN 13
978-987-515-266-3
ISBN 10
987-515-266-8
Publisher
Type
Libro
Pub. date
2001-07-01
Edition
1
Reprint
n/d
Language
Español
Subject
Cardiologia
Keywords
n/d
Local price
n/d
Format
8 pgs.; 21 x 28; Rústica/Paperback/Softback;
Sinopsis
n/d

How to cite this book?

CITATION (APA)

(Knauf y Emeriau, 2001)

BIBLIOGRAPHIC REFERENCE (APA)

Knauf, H. y Emeriau, J. (2001). Comparación de indapamida SR 1,5 mg. con 5 mg. de amlodipino y 25 mg. de hidrocloratiazida en pacientes hipertensos de edad avanzada. Florida, Argentina: Waverly Hispánica

¿Where and when the book Comparación de indapamida SR 1,5 mg. con 5 mg. de amlodipino y 25 mg. de hidrocloratiazida en pacientes hipertensos de edad avanzada was published?

This book has been published in Argentina, in Florida, BA. It was published in 2001.

Código de Barras de '.9789875152663.'
Group Prefix
978-987
Publisher Prefix
978-987-515
Capacity
1.000
Used
589
58%
Registrer
n/d
URL
n/d
Address
Florida, BA - Argentina

Reviews

There is no review for this title yet. Be the first one!

Comments